Inventor · disambiguated record
James Inglese
Also filed as: INGLESE JAMES
21 granted patents·11 pending applications·414 citations·filing 1988–2021
94Inventor score
Top patents by PatentIndex Score
32 records- 0195US5876946AHigh-throughput assayPHARMACOPEIA INC·Filed 1997·Granted Mar 2, 1999·213 cites·38 claims
- 0292US8841305B2Activators of the human pyruvate kinase M2 receptorTHOMAS CRAIG J·Filed 2009·Granted Sep 23, 2014·24 cites·26 claims
- 0389US6335176B1Incorporation of phosphorylation sitesPHARMACOPEIA INC·Filed 1998·Granted Jan 1, 2002·98 cites·16 claims
- 0488US9382229B2Compounds and methods of use thereof for treating neurodegenerative disordersZACK DONALD J·Filed 2012·Granted Jul 5, 2016·6 cites·2 claims
- 0576US6943161B2Pyrimidine and triazine kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Sep 13, 2005·7 cites·30 claims
- 0671US6406869B1Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agentsPHARMACOPEIA INC·Filed 1999·Granted Jun 18, 2002·35 cites·12 claims
- 0766US7037916B2Pyrimidine derivatives as IL-8 receptor antagonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted May 2, 2006·3 cites·33 claims
- 0863US9290512B2Activators of human pyruvate kinaseUS HEALTH·Filed 2014·Granted Mar 22, 2016·0 cites·13 claims
- 0962US6806056B2Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as both the capture agent and detecting agentPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Oct 19, 2004·5 cites·9 claims
- 1061US11065247B2Compositions and methods for the treatment of Zellweger spectrum disorderHACIA JOSEPH·Filed 2019·Granted Jul 20, 2021·0 cites·16 claims
- 1160US9296729B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2014·Granted Mar 29, 2016·0 cites·38 claims
- 1258US9707230B2Activators of human pyruvate kinaseUS HEALTH·Filed 2016·Granted Jul 18, 2017·0 cites·21 claims
- 1358US9187457B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2013·Granted Nov 17, 2015·0 cites·21 claims
- 1458US8937067B2Activators of human pyruvate kinaseTHOMAS CRAIG J·Filed 2012·Granted Jan 20, 2015·0 cites·12 claims
- 1558US2021315885A1Compositions and methods for the treatment of zellweger spectrum disorderHACIA JOSEPH·Filed 2021·Application pending·0 cites
- 1657US8741259B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsGERSHENGORN MARVIN C·Filed 2008·Granted Jun 3, 2014·0 cites·28 claims
- 1757US6156520ASite-specific bioconjugates of chemokines and their use in assaysPHARMACOPEIA INC·Filed 1997·Granted Dec 5, 2000·20 cites·21 claims
- 1857US2020399318A1Peptide inhibitors of phosphoglycerate mutase and methods of useUS HEALTH·Filed 2020·Application pending·0 cites
- 1956US11324725B2Compositions and methods for the inhibition of pruritusUS HEALTH·Filed 2018·Granted May 10, 2022·0 cites·2 claims
- 2056US10808010B2Peptide inhibitors of phosphoglycerate mutase and methods of useUS HEALTH·Filed 2017·Granted Oct 20, 2020·0 cites·16 claims
- 2156US9458141B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2015·Granted Oct 4, 2016·0 cites·7 claims
- 2254US2005277642A1Pyrimidine kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2005·Application pending·0 cites
- 2350US2018265934A1Coincidence reporter gene systemUS HEALTH·Filed 2018·Application pending·0 cites
- 2449US2016024600A1Coincidence reporter gene systemUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SER·Filed 2013·Application pending·0 cites
- 2549US2023406859A1Methotrexate analogs and methods of useUS HEALTH·Filed 2021·Application pending·0 cites
- 2649US2018000814A1Compositions and methods for the treatment of zellweger spectrum disorderHACIA JOSEPH·Filed 2017·Application pending·0 cites
- 2745US2006270841A1Assays to monitor amyloid precursor protein processingESPESETH AMY S·Filed 2003·Application pending·0 cites
- 2844US2014080787A1Method for the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) DiseaseNAT INST OF HEALTH US DEPT OF HEALTH AND HUMAN SERVICES·Filed 2013·Application pending·0 cites
- 2941US11474097B2Method of identifying a compound which affects the multienzyme metabolic assembly of glucose metabolism and its association with cell cycle progression in cancer cellsUNIV MARYLAND·Filed 2019·Granted Oct 18, 2022·0 cites·11 claims
- 3037US4999424AGAR transformylase inhibitorUNIV PENNSYLVANIA·Filed 1988·Granted Mar 12, 1991·3 cites·17 claims
- 3137US2019135804A1Compositions and methods for the inhibition of pruritusUS HEALTH·Filed 2018·Application pending·0 cites
- 3234US2005164311A1Biological assay detection methodFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →